Mid-Sized Pharmas Mostly Seeing Valuations Rise During Pandemic

 
• By Joseph Haas
  
Conceptual image of increasing value of money shown by a coin from small to large number
Valuations rose for many mid-sized biopharmas during Q1 despite the ongoing pandemic
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip